Elevance Health (ELV) Income from Non-Controlling Interests (2021 - 2026)

Elevance Health (ELV) has reported Income from Non-Controlling Interests for 6 consecutive years, with -$9.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Income from Non-Controlling Interests fell 1000.0% year-over-year to -$9.0 million; the TTM figure through Jun 2026 stood at -$16.0 million (down 45.45% YoY), while the FY2025 annual figure was -$1.0 million, up 88.89% from the prior year.
• Income from Non-Controlling Interests fell to -$9.0 million in Q2 2026 per ELV's latest filing, from -$4.0 million in the prior quarter.
• Across five years, Income from Non-Controlling Interests topped out at $15.0 million in Q1 2023 and bottomed at -$25.0 million in Q4 2023.
• Historically, Income from Non-Controlling Interests has averaged -$1.4 million across 5 years, with a median of -$1.5 million in 2025.
• Annual changes were most pronounced in 2023 — Income from Non-Controlling Interests surged 320.0% — and 2026, when it slumped 1000.0%.
• Elevance Health's Income from Non-Controlling Interests stood at $12.0 million in 2022, then slumped by 308.33% to -$25.0 million in 2023, then soared by 80.0% to -$5.0 million in 2024, then soared by 80.0% to -$1.0 million in 2025, then sank by 800.0% to -$9.0 million in 2026.
• Business Quant data shows ELV's Income from Non-Controlling Interests at -$9.0 million in Q2 2026, -$4.0 million in Q1 2026, and -$1.0 million in Q4 2025.